BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Head and neck cancer AND ATP1A1, P05023, MGC51750, MGC3285, ENSG00000163399, 476
160 results:

  • 1. Prognostic value of pre-treatment [
    Dong Z; Wang GY; Dai DY; Qin GJ; Tang LL; Xu C; Ma J
    BMC Cancer; 2024 Apr; 24(1):466. PubMed ID: 38622555
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Incidence, mortality and survival rates of lip, oral cavity and salivary glands cancers in Singapore: A half-century time trend analysis (1968-2017).
    Peres MA; Li H; Nascimento GG; Leite FRM
    Community Dent Oral Epidemiol; 2024 Jun; 52(3):302-312. PubMed ID: 38462696
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. A novel CT-based radiomics model for predicting response and prognosis of chemoradiotherapy in esophageal squamous cell carcinoma.
    Kasai A; Miyoshi J; Sato Y; Okamoto K; Miyamoto H; Kawanaka T; Tonoiso C; Harada M; Goto M; Yoshida T; Haga A; Takayama T
    Sci Rep; 2024 Jan; 14(1):2039. PubMed ID: 38263395
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Effects of personalized oral exercises on swallowing function among patients with oral cancer after free flap transplantation: a cluster randomized controlled trial.
    Zhang J; Wu HY; Shan XF; Cai ZG; Zhang L; Yang Y
    Int J Oral Maxillofac Surg; 2024 May; 53(5):355-363. PubMed ID: 38143220
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Association of miR-203 Expression with Prognostic Value in Patients with Esophageal cancer: A Systematic Review and Meta-Analysis.
    Cheng Q; Chen L; Ni L
    J Invest Surg; 2023 Dec; 36(1):2285780. PubMed ID: 38047456
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Oral fungal profiling and risk of nasopharyngeal carcinoma: a population-based case-control study.
    Chen Y; Li W; Chang ET; Debelius JW; Manoharan L; Zheng Y; Li Y; Huang G; Adami HO; Knight R; Cai Y; Zhang Z; Ye W
    EBioMedicine; 2023 Oct; 96():104813. PubMed ID: 37776725
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Nasopharyngeal cancer Incidence and Mortality in 185 Countries in 2020 and the Projected Burden in 2040: Population-Based Global Epidemiological Profiling.
    Zhang Y; Rumgay H; Li M; Cao S; Chen W
    JMIR Public Health Surveill; 2023 Sep; 9():e49968. PubMed ID: 37728964
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Development of Electronic Health Record-Based Machine Learning Models to Predict Barrett's Esophagus and Esophageal Adenocarcinoma Risk.
    Iyer PG; Sachdeva K; Leggett CL; Codipilly DC; Abbas H; Anderson K; Kisiel JB; Asfahan S; Awasthi S; Anand P; Kumar M P; Singh SP; Shukla S; Bade S; Mahto C; Singh N; Yadav S; Padhye C
    Clin Transl Gastroenterol; 2023 Oct; 14(10):e00637. PubMed ID: 37698203
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Clinical observational study on the efficacy of induction chemotherapy sequential concurrent radiotherapy combined with targeted therapy in patients with locally advanced EGFR-positive nasopharyngeal carcinoma: prediction model construction and efficacy testing.
    Luo Y; Xiang X; Ma X
    Eur Arch Otorhinolaryngol; 2023 Dec; 280(12):5409-5416. PubMed ID: 37530857
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Stereotactic radiosurgery for sarcoma metastases to the brain: a single-institution experience.
    Zamarud A; Park DJ; Dadey DYA; Yoo KH; Marianayagam NJ; Yener U; Szalkowski GA; Pollom E; Soltys S; Chang SD; Meola A
    Neurosurg Focus; 2023 Aug; 55(2):E7. PubMed ID: 37527671
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Significance of Tumor-Stroma Ratio (TSR) in Predicting Outcomes of Malignant Tumors.
    Pyo JS; Kim NY; Min KW; Kang DW
    Medicina (Kaunas); 2023 Jul; 59(7):. PubMed ID: 37512068
    [No Abstract]    [Full Text] [Related]  

  • 12. Meta analysis of the second course of radiotherapy for recurrent esophageal cancer1.
    Xu P; Liu Y; Wu S; Cheng D; Sun Z
    J Xray Sci Technol; 2024; 32(1):141-155. PubMed ID: 37424494
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Association of pre-treatment lymphocyte-monocyte ratio with survival outcome in patients with head and neck cancer treated with chemoradiation.
    Yu B; Ma SJ; Khan M; Gill J; Iovoli A; Fekrmandi F; Farrugia MK; Wooten K; Gupta V; McSpadden R; Kuriakose MA; Markiewicz MR; Al-Afif A; Hicks WL; Seshadri M; Ray AD; Repasky EA; Singh AK
    BMC Cancer; 2023 Jun; 23(1):572. PubMed ID: 37344761
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Nomograms incorporating primary tumor response at mid-radiotherapy to predict survival in locoregionally advanced nasopharyngeal carcinoma.
    Liu X; Huang J; Qin Y; Zhang Z; Wu B; Yang K
    Head Neck; 2023 Aug; 45(8):1922-1933. PubMed ID: 37204765
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Dose escalation in oropharyngeal cancer: a comparison of simultaneous integrated boost and brachytherapy boost.
    Embring A; Onjukka E; Mercke C; Lax I; Berglund A; Friesland S
    Radiat Oncol; 2023 Apr; 18(1):65. PubMed ID: 37029424
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Correlation between expression of Lin28B and C-myc in patients with laryngeal squamous cell carcinoma and clinicopathological features and prognosis.
    Liao F; Cao Y; Huang M; Chu L; Wang T
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Feb; 48(2):165-171. PubMed ID: 36999462
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Salivary gland tumours: an epidemiological review of non-neoplastic and neoplastic pathology.
    Mckenzie J; Lockyer J; Singh T; Nguyen E
    Br J Oral Maxillofac Surg; 2023 Jan; 61(1):12-18. PubMed ID: 36623970
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Construction of a novel cuproptosis-related gene signature for predicting prognosis and estimating tumor immune microenvironment status in papillary thyroid carcinoma.
    Wang L; Yao B; Yang J; Tian Z; He J
    BMC Cancer; 2022 Nov; 22(1):1131. PubMed ID: 36333684
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. The prevalence of thyroid nodules and its factors among Chinese adult women: A cross-sectional study.
    Dong X; Li Y; Xie J; Li L; Wan Z; Kang Y; Luo Y; Wang J; Duan Y; Ding S; Cheng AS
    Front Endocrinol (Lausanne); 2022; 13():967380. PubMed ID: 36060984
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. LncRNA atp1a1-AS1 inhibits cell proliferation and promotes cell apoptosis in thyroid carcinoma by regulating the miR-620/IRF2BP2 axis.
    Jia J; Liu Y; Yang X; Wu Z; Xu X; Kang F; Liu Y
    Am J Med Sci; 2023 Jan; 365(1):73-83. PubMed ID: 36002076
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 8.